Hepatitis C reinfection after successful antiviral treatment among people who inject drugs: A meta-analysis
Background & Aims HCV reinfection following successful treatment can compromise
treatment outcomes. This systematic review assessed the rate of HCV reinfection following …
treatment outcomes. This systematic review assessed the rate of HCV reinfection following …
HCV epidemiology in high-risk groups and the risk of reinfection
Injecting risk behaviours among people who inject drugs (PWID) and high-risk sexual
practices among men who have sex with men (MSM) are important routes of hepatitis C …
practices among men who have sex with men (MSM) are important routes of hepatitis C …
EASL recommendations on treatment of hepatitis C: final update of the series☆
Hepatitis C virus (HCV) infection is a major cause of chronic liver disease, with
approximately 71 million chronically infected individuals worldwide. Clinical care for patients …
approximately 71 million chronically infected individuals worldwide. Clinical care for patients …
EASL recommendations on treatment of hepatitis C 2018
Hepatitis C virus (HCV) infection is a major cause of chronic liver disease, with
approximately 71 million chronically infected individuals worldwide. Clinical care for patients …
approximately 71 million chronically infected individuals worldwide. Clinical care for patients …
Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission
GS Cooke, I Andrieux-Meyer, TL Applegate… - The lancet …, 2019 - thelancet.com
Viral hepatitis is a major public health threat and a leading cause of death worldwide.
Annual mortality from viral hepatitis is similar to that of other major infectious diseases such …
Annual mortality from viral hepatitis is similar to that of other major infectious diseases such …
Hepatitis C elimination among people who inject drugs: challenges and recommendations for action within a health systems framework
E Day, M Hellard, C Treloar, J Bruneau… - Liver …, 2019 - Wiley Online Library
The burden of hepatitis C infection is considerable among people who inject drugs (PWID),
with an estimated prevalence of 39%, representing an estimated 6.1 million people who …
with an estimated prevalence of 39%, representing an estimated 6.1 million people who …
Elimination of HCV as a public health concern among people who inject drugs by 2030–What will it take to get there?
Elimination of HCV as a public health concern among people w... : African Journal of
Reproduction and Gynaecological Endoscopy Elimination of HCV as a public health concern …
Reproduction and Gynaecological Endoscopy Elimination of HCV as a public health concern …
[HTML][HTML] The management of chronic hepatitis C: 2018 guideline update from the Canadian Association for the Study of the Liver
The treatment of hepatitis C has become safer, better tolerated and more effective owing to
the availability of direct-acting antivirals for nearly all patients; this guideline advocates …
the availability of direct-acting antivirals for nearly all patients; this guideline advocates …
Direct-acting antiviral agents for HCV infection affecting people who inject drugs
Globally, 12 million people are estimated to have injected drugs in the past year, 50% of
whom have chronic HCV infection, with people who have previously injected drugs …
whom have chronic HCV infection, with people who have previously injected drugs …
Recommendations for the management of hepatitis C virus infection among people who inject drugs
In high income countries, the majority of new and existing hepatitis C virus (HCV) infections
occur among people who inject drugs (PWID). In many low and middle income countries …
occur among people who inject drugs (PWID). In many low and middle income countries …